2017 UCSF‐Gladstone CFAR Research Symposium Friday, May 19, 2017 – Mission Bay Conference Center HIV Vaccines: From Prevention to Cure 8:00‐9:00 Breakfast 9:00‐9:05 Welcome and Introductions 9:05‐10:00 Prevention Keynote: Mark Feinberg, MD, PhD HIV Vaccine Development: How will we President and CEO translate scientific opportunity into International AIDS Vaccine Initiative public health impact? 10:00‐10:40 Human Monoclonal Antibodies for Pre‐ John R. Mascola, MD Exposure Prophylaxis (PrEP) of HIV‐1 Director of the Dale and Betty Bumpers Vaccine Research Center Infection National Institute of Allergy and Infectious Diseases (NIAID) National Institutes of Health 10:40‐11:20 Progress in Advancing Vaccine Concepts Julie McElrath, MD, PhD to P5 Efficacy Trials Senior Vice President and Director Vaccine and Infectious Disease Division Member, Vaccine and Infectious Disease Division Member, Clinical Research Division Fred Hutchinson Cancer Research Center Professor of Medicine Adjunct Professor of Pathobiology, Global Health, and Laboratory Medicine, University of Washington 11:20‐12:00 Defining Correlates of Protection against Galit Alter, PhD HIV/SIV Associate Professor of Medicine Samana Cay MGH Research Scholar Director, Ragon Institute Imaging Core Director, Harvard Center for Aids Research Immunology Core Harvard University 12:00‐1:00 Lunch 1:00‐1:40 Ad26 Based Vaccines for HIV and Beyond Dan H. Barouch, MD, PhD Professor of Medicine Harvard Medical School Director, Center for Virology and Vaccine Research Beth Israel Deaconess Medical Center Steering Committee, Ragon Institute of MGH, MIT, and Harvard 1:40‐2:20 Building on Prevention: How prophylactic Nicole Frahm, PhD vaccine trials inform HIV cure Associate Member, Vaccine and Infectious Disease Division Fred Hutchinson Cancer Research Center Associate Director for Laboratory Science HIV Vaccine Trials Network Associate Professor and Graduate Faculty, Global Health University of Washington 2:20‐3:00 Targeting HIV where it hurts Tomas Hanke, PhD, MSc Professor of Vaccine Immunology University of Oxford Distinguished Professor Kumamoto University 3:00‐3:55 Treatment Keynote: Louis J. Picker, MD Barriers to a Cure and Therapy: What will Professor and Associate Director a vaccine need to do to be a success? Vaccine and Gene Therapy Institute Oregon Health & Science University 3:55‐4:00 Closing .